Notify me when Andrew J. Schwab files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SKYE | SKYE BIOSCIENCE, INC. | Common Stock, par value $0.001 | 34% | $15,119,125 | -$203,807 | 11,541,317 | -1.3% | Andrew J. Schwab | 12 Dec 2025 |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | Common Stock | 12% | $8,392,800 | 5,869,091 | Andrew J. Schwab | 09 Sep 2025 | ||
| VOR | VOR BIOPHARMA INC. | Common Stock, par value $0.0001 per share | 3.5% | $4,422,863 | 4,422,863 | Andrew J. Schwab | 08 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|